Literature DB >> 15563178

A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.

D Allen Annis1, Naim Nazef, Cheng-Chi Chuang, Margaret Porter Scott, Huw M Nash.   

Abstract

To realize the full potential of combinatorial chemistry-based drug discovery, generic and efficient tools must be developed that apply the strengths of diversity-oriented chemical synthesis to the identification and optimization of lead compounds for disease-associated protein targets. We report an affinity selection-mass spectrometry (AS-MS) method for protein-ligand affinity ranking and the classification of ligands by binding site. The method incorporates the following steps: (1) an affinity selection stage, where protein-binding compounds are selected from pools of ligands in the presence of varying concentrations of a competitor ligand, (2) a first chromatography stage to separate unbound ligands from protein-ligand complexes, and (3) a second chromatography stage to dissociate the ligands from the complexes for identification and quantification by MS. The ability of the competitor ligand to displace a target-bound library member, as measured by MS, reveals the binding site classification and affinity ranking of the mixture components. The technique requires no radiolabel incorporation or direct biochemical assay, no modification or immobilization of the compounds or target protein, and all reaction components, including any buffers or cofactors required for protein stability, are free in solution. We demonstrate the method for several compounds of wide structural variety against representatives of the most important protein classes in contemporary drug discovery, including novel ATP-competitive and allosteric inhibitors of the Akt-1 (PKB) and Zap-70 kinases, and previously undisclosed antagonists of the M(2) muscarinic acetylcholine receptor, a G-protein coupled receptor (GPCR). The theoretical basis of the technique is analyzed mathematically, allowing quantitative estimation of binding affinities and, in the case of allosteric interaction, absolute determination of binding cooperativity. The method is readily applicable to high-throughput screening hit triage, combinatorial library-based affinity optimization, and developing structure-activity relationships among multiple ligands to a given receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563178     DOI: 10.1021/ja048365x

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  17 in total

1.  A new screening assay for allosteric inhibitors of cSrc.

Authors:  Jeffrey R Simard; Sabine Klüter; Christian Grütter; Matthäus Getlik; Matthias Rabiller; Haridas B Rode; Daniel Rauh
Journal:  Nat Chem Biol       Date:  2009-04-26       Impact factor: 15.040

2.  In-solution enrichment identifies peptide inhibitors of protein-protein interactions.

Authors:  Fayçal Touti; Zachary P Gates; Anupam Bandyopadhyay; Guillaume Lautrette; Bradley L Pentelute
Journal:  Nat Chem Biol       Date:  2019-03-18       Impact factor: 15.040

3.  Discovery of a Novel Series of CHK1 Kinase Inhibitors with a Distinctive Hinge Binding Mode.

Authors:  Xiaohua Huang; Cliff C Cheng; Thierry O Fischmann; José S Duca; Xianshu Yang; Matthew Richards; Gerald W Shipps
Journal:  ACS Med Chem Lett       Date:  2012-01-20       Impact factor: 4.345

4.  HAMS: High-Affinity Mass Spectrometry Screening. A High-Throughput Screening Method for Identifying the Tightest-Binding Lead Compounds for Target Proteins with No False Positive Identifications.

Authors:  Kasun P Imaduwage; Eden P Go; Zhikai Zhu; Heather Desaire
Journal:  J Am Soc Mass Spectrom       Date:  2016-09-06       Impact factor: 3.109

5.  High-Throughput Assessment of Structural Continuity in Biologics.

Authors:  Caterina Musetti; Mark F Bean; Geoffrey T Quinque; Christopher Kwiatkowski; Lawrence M Szewczuk; John Baldoni; Matthew A Zajac
Journal:  Anal Chem       Date:  2018-02-08       Impact factor: 6.986

6.  Small molecule inhibition of the TNF family cytokine CD40 ligand through a subunit fracture mechanism.

Authors:  Laura F Silvian; Jessica E Friedman; Kathy Strauch; Teresa G Cachero; Eric S Day; Fang Qian; Brian Cunningham; Amy Fung; Lihong Sun; Gerald W Shipps; Lihe Su; Zhongli Zheng; Gnanasambandam Kumaravel; Adrian Whitty
Journal:  ACS Chem Biol       Date:  2011-04-20       Impact factor: 5.100

7.  Affinity Selection-Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase Inhibitor.

Authors:  Scott S Walker; David Degen; Elliott Nickbarg; Donna Carr; Aileen Soriano; Mihir Mandal; Ronald E Painter; Payal Sheth; Li Xiao; Xinwei Sher; Nicholas Murgolo; Jing Su; David B Olsen; Richard H Ebright; Katherine Young
Journal:  ACS Chem Biol       Date:  2017-03-31       Impact factor: 5.100

8.  Multiplexed Small-Molecule-Ligand Binding Assays by Affinity Labeling and DNA Sequence Analysis.

Authors:  Bo Cai; Casey J Krusemark
Journal:  Angew Chem Int Ed Engl       Date:  2021-12-03       Impact factor: 15.336

9.  Hydrogen exchange-mass spectrometry measures stapled peptide conformational dynamics and predicts pharmacokinetic properties.

Authors:  Xiangguo Eric Shi; Thomas E Wales; Carl Elkin; Noriyuki Kawahata; John R Engen; D Allen Annis
Journal:  Anal Chem       Date:  2013-11-14       Impact factor: 6.986

10.  Activation state-selective kinase inhibitor assay based on ion mobility-mass spectrometry.

Authors:  Jessica N Rabuck; Suk-Joon Hyung; Kristin S Ko; Christel C Fox; Matthew B Soellner; Brandon T Ruotolo
Journal:  Anal Chem       Date:  2013-07-23       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.